INASL 关于预防的立场声明 ,印度乙型肝炎病毒感染的诊断和管理 : 安达曼声明。
关键词: AASLD, American Association for the Study of Liver Diseases ADV, adefovir dipivoxil ALT, alanine aminotransferase APASL, Asian Pacific Association for the Study of the Liver ART, antiretroviral therapy AST, aspartate aminotransferase Anti-HBe, antibodies to hepatitis B envelope antigen CBC, complete blood count CDC, Center for Disease Control CHB, chronic hepatitis B CU-HCC, Chinese University-Hepatocellular Carcinoma DAA, direct-acting antiviral DILI, drug induced liver injury DNA, deoxyribonucleic acid EASL, European Association for the Study of the Liver ETV, entecavir GAG-HCC, Guide with Age, Gender, HBV DNA, Core Promoter Mutations and Cirrhosis-Hepatocellular Carcinoma GGT, gamma-glutamyl transferase GRADE, Grading of Recommendations Assessment Development and Evaluation HBIG, hepatitis B immune globulin HBV, hepatitis B virus HBeAg, hepatitis B envelope antigen HCC, hepatocellular carcinoma HCV, hepatitis C virus HDV, hepatitis D virus HIV, human immunodeficiency virus IFN-α, interferon alpha INASL, Indian National Association for Study of the Liver INR, international normalized ratio KASL, Korean Association for the Study of the Liver LAM, lamivudine NA, nucleos(t)ide analogue PAGE-B, platelets, age, gender—hepatitis B PVNR, primary virological non-response PVR, partial virological response PegIFN-α, pegylated interferon alpha RCT, randomized controlled trial REACH-B, risk estimation for hepatocellular carcinoma in chronic hepatitis B SOVR, sustained off-therapy virological response TAF, tenofovir alafenamide TDF, tenofovir disoproxil fumarate TDV, telbivudine TSH, thyroid-stimulating hormone VR, virologic response WHO, World Health Organization anti-HBs, antibody to hepatitis B surface antigen cccDNA, covalently closed circular DNA chronic hepatitis cirrhosis eGFR, estimated glomerular filtration rate hepatitis B jaundice liver failure
来 源:
DOI:10.1016/j.jceh.2017.12.001
PDF(Sci-hub)
PDF(Pubmed)